Literature DB >> 27823951

Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.

Luis García de Guadiana Romualdo1, Patricia Esteban Torrella2, Sergio Rebollo Acebes3, María Dolores Albaladejo Otón2, Roberto Jiménez Sánchez3, Ana Hernando Holgado2, Enrique Jiménez Santos2, Alejandro Ortín Freire3.   

Abstract

BACKGROUND: Presepsin is a promising biomarker for the diagnosis and prognosis of sepsis. However, results reported about its value to diagnose sepsis in an emergency department (ED) are controversial, probably due to differences in the design of the studies. We have evaluated the diagnostic accuracy of presepsin for infection and sepsis, compared with procalcitonin (PCT) and C-reactive protein (CRP), in patients presenting to the emergency department (ED) with suspected infection.
METHODS: 223 patients with suspected infection were enrolled for the study. Blood samples were collected on admission for measurement of biomarkers. Definitive diagnosis was obtained afterwards by analysis of digital medical records. Receiver operating characteristic (ROC) curve analysis was conducted to determine the diagnostic accuracy.
RESULTS: Infection was confirmed in 200 patients, including 130 with non-complicated infection and 70 with sepsis. Median CRP, PCT and presepsin levels were significantly higher in patients with infection and sepsis. PCT was the biomarker with the highest performance for infection (ROC AUC: 0.910); for sepsis, PCT (ROC AUC: 0.815) and presepsin (ROC AUC: 0.775) shown a similar performance.
CONCLUSION: Although presepsin is a valuable biomarker for diagnosis of infection and sepsis, its diagnostic accuracy in our study does not improve that of PCT. Its introduction in clinical practice is not justified.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Diagnostic accuracy; Emergency Department; Infection; Presepsin; Procalcitonin; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 27823951     DOI: 10.1016/j.cca.2016.11.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  The Utility of Neutrophil CD64 and Presepsin as Diagnostic, Prognostic, and Monitoring Biomarkers in Neonatal Sepsis.

Authors:  Heba E Hashem; Rania M Abdel Halim; Sherin A El Masry; Amira M Mokhtar; Noureldin M Abdelaal
Journal:  Int J Microbiol       Date:  2020-11-01

2.  Advances and Pitfalls in Using Laboratory Biomarkers for the Diagnosis and Management of Sepsis.

Authors:  Dunja Rogić; Gordana Fressl Juroš; József Petrik; Ana Lončar Vrančić
Journal:  EJIFCC       Date:  2017-05-01

3.  Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis.

Authors:  Chin-Chieh Wu; Hao-Min Lan; Shih-Tsung Han; Chung-Hsien Chaou; Chun-Fu Yeh; Su-Hsun Liu; Chih-Huang Li; Gerald N Blaney; Zhen-Ying Liu; Kuan-Fu Chen
Journal:  Ann Intensive Care       Date:  2017-09-06       Impact factor: 6.925

Review 4.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

5.  Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study.

Authors:  Jaskirat Arora; Jennifer A Klowak; Sameer Parpia; Marcelo Zapata-Canivilo; Walaa Faidi; Christopher Skappak; Rachael Gregoris; Colin A Kretz; Dhruva J Dwivedi; Kerstin de Wit; Michelle Welsford; Alison Fox-Robichaud
Journal:  Crit Care Explor       Date:  2021-04-26

6.  Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.

Authors:  Sukyo Lee; Juhyun Song; Dae Won Park; Hyeri Seok; Sejoong Ahn; Jooyeong Kim; Jonghak Park; Han-Jin Cho; Sungwoo Moon
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

7.  The postoperative cognitive dysfunction induced by central inflammation with possible involvement of the gut-brain axis.

Authors:  Chuantao Lin; Jing Wang; Yuping Wang; Chanjuan Chen; Xiang Gao
Journal:  Clinics (Sao Paulo)       Date:  2022-09-19       Impact factor: 2.898

Review 8.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

Review 9.  A Novel Combination of Biomarkers to Herald the Onset of Sepsis Prior to the Manifestation of Symptoms.

Authors:  Hallie H Dolin; Thomas J Papadimos; Stanislaw Stepkowski; Xiaohuan Chen; Zhixing K Pan
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

10.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.